Antiepileptic Potential of Matrine via Regulation the Levels of Gamma-Aminobutyric Acid and Glutamic Acid in the Brain

Jun Xiang, Yu–Gang JiangInternational Journal of Molecular Sciences 2013 · DOI

TL;DR

This study investigates the antiepileptic potential of matrine, a natural compound, and its underlying molecular mechanisms. The research demonstrates that matrine exhibits significant anticonvulsant effects in mouse models of epilepsy, likely by modulating the balance of key neurotransmitters, GABA and glutamate, and upregulating GABA synthesis enzymes and receptors.

What Problem Does This Paper Address?

Epilepsy affects millions worldwide and current antiepileptic drugs often come with significant side effects, leading to patient reluctance and a continuous need for safer, more effective treatments. The paper addresses this by exploring the potential of matrine, a compound derived from Sophora flavescens, as a novel antiepileptic agent. While matrine is known for various physiological activities, its antiepileptic properties had not been previously reported, presenting a gap in knowledge that this research aims to fill.

Methods

The researchers employed a multi-pronged approach to evaluate matrine's antiepileptic effects and elucidate its mechanism:

  • Seizure Models: Two standard animal models were used to induce seizures:
  • Maximal Electroshock (MES): This model induces generalized tonic-clonic seizures, mimicking a common type of human epilepsy.
  • Pentylenetetrazole (PTZ): This model induces generalized myoclonic and absence seizures, also relevant to human epilepsy.
  • Behavioral Tests: Beyond direct seizure induction, the study assessed matrine's effects on:
  • Pentobarbital Sodium-Induced Anesthetizing Time: This test evaluates sedative effects, as some antiepileptic drugs can also cause sedation.
  • Locomotor Activity: This measures general motor function, again to assess potential side effects.
  • Neurotransmitter Analysis: The levels of key neurotransmitters, aspartic acid (Asp), gamma-aminobutyric acid (GABA), glutamic acid (Glu), and glycine (Gly), were measured in the brains of PTZ-induced seizure mice using HPLC.
  • Molecular Mechanism Investigation: In chronic epileptic rats, Western blotting was used to examine the expression levels of:
  • GAD 65: An enzyme crucial for GABA synthesis.
  • GABAA and GABAB Receptors: Receptors that mediate GABA's inhibitory effects.

Datasets

Not discussed in the paper. The study utilized animal models and conducted in-vivo experiments.

Key Insights and Ideas

  • Matrine as a Promising Antiepileptic: The most significant insight is that matrine demonstrates clear and dose-dependent anticonvulsant activity across different seizure models. This suggests it could be a valuable addition to the antiepileptic drug arsenal.
  • Neurotransmitter Modulation: The study strongly suggests that matrine's antiepileptic action is linked to its ability to restore the balance between excitatory (glutamate) and inhibitory (GABA) neurotransmitters. Specifically, increasing GABA and decreasing glutamate is a well-established strategy for epilepsy treatment.
  • Targeting GABA Synthesis and Receptors: The observed upregulation of GAD 65 (GABA synthesis) and GABAA receptors points to a specific molecular pathway through which matrine exerts its effects. This provides a concrete target for further drug development.
  • Favorable Side Effect Profile (Implied): While not the primary focus, the tests on anesthetic time and locomotor activity suggest that matrine may have a more favorable side effect profile compared to some existing drugs, as it didn't excessively prolong anesthesia or impair motor function at effective doses.

Key Results

  • MES and PTZ Seizure Protection: Matrine significantly reduced tonic-clonic seizures induced by MES and clonic seizures induced by PTZ in a dose-dependent manner. At higher doses (30 and 60 mg/kg), matrine completely abolished tonic seizures in the MES model.
  • Mortality Reduction: Matrine treatment significantly decreased mortality rates in PTZ-induced seizures, with the highest dose (60 mg/kg) showing a substantial reduction.
  • Neurotransmitter Changes: Matrine treatment led to a significant increase in brain GABA levels and a significant decrease in brain glutamate levels in PTZ-induced seizure mice.
  • Molecular Upregulation: In epileptic rats, matrine treatment significantly upregulated the expression of GAD 65 and GABAA receptors in the brain.
  • Sedative and Motor Activity: Matrine prolonged pentobarbital-induced anesthetizing time and decreased locomotor activity at higher doses, indicating some sedative and motor-impairing effects, but these were generally observed at doses that also showed significant antiepileptic effects.

Limitations and Future Work

  • Animal Models: While standard, MES and PTZ models do not perfectly replicate the complexity of human epilepsy. Further studies in more complex or human-relevant models would be beneficial.
  • Mechanism Specificity: While GAD 65 and GABAA upregulation are identified, other potential molecular targets and pathways might be involved and warrant further investigation.
  • Long-term Effects and Toxicity: The study focused on acute effects. Long-term safety and efficacy studies, as well as detailed toxicity profiling, would be necessary for clinical translation.
  • Clinical Translation: The paper suggests matrine can be developed as an effective drug for treating epilepsy. Future work should focus on preclinical development, including pharmacokinetics, pharmacodynamics, and ultimately, clinical trials.

Summary updated

Abstract

Our present study aimed to determine the antiepileptic activity of matrine, and explore the possible molecular mechanism. To evaluate the antiepileptic activity of matrine, seizures in mice induced by PTZ and MES were established, then the pentobarbital sodium-induced anaesthetizing time and locomotor activity tests in mice were also carried out. For the molecular mechanism investigations, contents of aspartic acid (Asp), gamma-aminobutyric acid (GABA), glutamic acid (Glu), glycine (Gly) in seizures mice were determined; then, the chronic seizures rats induced by PTZ were prepared, and western blotting was used to determine the expressions of GAD 65, GABAA and GABAB in the brains. In the results, matrine showed significant antiepileptic effects on seizures mice induced by MES and PTZ. Moreover, the pentobarbital sodium-induced anaesthetizing time and locomotor activity tests were also demonstrated that matrine had obvious antiepileptic effects. Additionally, our results revealed that after treatment with matrine, contents of GABA can be elevated, and the contents of Glu were obviously decreased. Furthermore, western blotting revealed that the mechanism regarding the antiepileptic effect of may be related to the up-regulations of GAD 65 and GABAA in the brain. Collectively, we suggested that matrine can be developed as an effective antiseptic drug.
BibTeX
@article{xiang2013antiepileptic,
  author = {Jun Xiang and Yu–Gang Jiang},
  title = {{Antiepileptic Potential of Matrine via Regulation the Levels of Gamma-Aminobutyric Acid and Glutamic Acid in the Brain}},
  journal = {International Journal of Molecular Sciences},
  year = {2013},
  doi = {10.3390/ijms141223751},
}
Figure